Neurologic Outcomes in People With MS Treated With Immune Checkpoint Inhibitors for Oncologic Indications
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications
Neurology 2024 Dec 10;103(11)e210003, CM Quinn, P Rajarajan, AJ Gill, H Kopinsky, AB Wolf, CS de Camargo, J Lamb, TE Bacon, JC Murray, JC Probasco, KM Galetta, D Kantor, P Coyle, V Bhise, E Alvarez, SE Conway, S Bhattacharyya, I KisterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.